SeaStar Medical (NASDAQ:ICU) versus Solventum (NYSE:SOLV) Financial Review

SeaStar Medical (NASDAQ:ICU) and Solventum (NYSE:SOLV) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, dividends, earnings and analyst recommendations.

Earnings & Valuation

This table compares SeaStar Medical and Solventum”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$68,000.00	159.40	-$26.23 million	($11.63)	-0.14
Solventum	$8.25 billion	1.58	$475.72 million	$2.75	27.43

Solventum has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

1.7% of SeaStar Medical shares are held by institutional investors. 1.1% of SeaStar Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares SeaStar Medical and Solventum’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	N/A	N/A	-627.49%
Solventum	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings for SeaStar Medical and Solventum, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	0	0	0	0	0.00
Solventum	1	9	1	0	2.00

Solventum has a consensus target price of $79.86, indicating a potential upside of 5.85%. Given Solventum’s stronger consensus rating and higher probable upside, analysts clearly believe Solventum is more favorable than SeaStar Medical.

Summary

Solventum beats SeaStar Medical on 8 of the 11 factors compared between the two stocks.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.